These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 14114008)
21. Physiologic disposition and uricosuric effect of a keto analog of oxyphenbutazone (G-29701). SEEGMILLER JE; DAYTON PG; BURNS JJ Arthritis Rheum; 1960 Dec; 3():475-84. PubMed ID: 13749615 [No Abstract] [Full Text] [Related]
22. EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT. YUE TF; GUTMAN AB Am J Med; 1964 Dec; 37():885-98. PubMed ID: 14246090 [No Abstract] [Full Text] [Related]
23. 4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS. HALL AP; HOLLOWAY VP; SCOTT JT Ann Rheum Dis; 1964 Nov; 23(6):439-46. PubMed ID: 14229577 [No Abstract] [Full Text] [Related]
24. Spectrophotometric determination of dipyrone, phenylbutazone and oxyphenbutazone by their hydrolysis and Schiff base formation with 4-dimethylaminobenzaldehyde. Verma KK; Jain A; Patel N; Sanghi SK Farmaco Prat; 1987 Jul; 42(7):185-92. PubMed ID: 3622752 [No Abstract] [Full Text] [Related]
29. [SIDE-EFFECTS OF ANTI-INFLAMMATORY DRUGS USED IN RHEUMATOLOGY]. GONCALVES GW Hospital (Rio J); 1964 Jul; 66():205-26. PubMed ID: 14181571 [No Abstract] [Full Text] [Related]
30. [Mass spectrometric study on 3,5-dioxo-pyrazolidines and their methylation products]. Unterhalt B Arch Pharm (Weinheim); 1972 May; 305(5):334-7. PubMed ID: 5048254 [No Abstract] [Full Text] [Related]
31. THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT. KLINENBERG JR; GOLDFINGER SE; SEEGMILLER JE Ann Intern Med; 1965 Apr; 62():639-47. PubMed ID: 14274828 [No Abstract] [Full Text] [Related]
32. USE OF DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS. MASON RM Physiotherapy; 1964 Mar; 50():86-8. PubMed ID: 14130813 [No Abstract] [Full Text] [Related]
33. 3 YEARS' EXPERIENCE WITH OXYPHENBUTAZONE IN THE TREATMENT OF RHEUMATIC DISORDERS. SPERLING IL Appl Ther; 1964 Feb; 6():117-20. PubMed ID: 14117717 [No Abstract] [Full Text] [Related]
35. Interaction between plasma proteins and antirheumatic or new antiphlogistic drugs. Mizushima Y; Suzuki H Arch Int Pharmacodyn Ther; 1965 Sep; 157(1):115-24. PubMed ID: 5894772 [No Abstract] [Full Text] [Related]
36. A NEW APPROACH TO THROMBOEMBOLIC DISEASE. KAPPERT A; MONTIGEL C Vasc Dis; 1965 Jan; 2():39-42. PubMed ID: 14252943 [No Abstract] [Full Text] [Related]
37. MEDICAL MANAGEMENT OF CEREBROVASCULAR DISEASES. KUHN RA Angiology; 1964 Feb; 15():103-6. PubMed ID: 14118542 [No Abstract] [Full Text] [Related]
38. NON-STEROID ANTIRHEUMATIC DRUGS. FORD DK Can Med Assoc J; 1964 Sep; 91(12):659-60. PubMed ID: 14201254 [No Abstract] [Full Text] [Related]
39. ANTICOAGULANTS: ANOTHER VIEW. VEREL D C R Seances Soc Biol Fil; 1964; 1587():1135. PubMed ID: 14196164 [No Abstract] [Full Text] [Related]
40. [ASSESSMENT OF THE INSECTICIDAL ACTION OF SOME PYRAZOLONE DERIVATIVES]. FAVOROVA LA; DOLGOV GF Zh Mikrobiol Epidemiol Immunobiol; 1963 Jul; 40():7-11. PubMed ID: 14070209 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]